skip to main content

Steroid-induced osteoporosis — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyMusculoskeletal TherapeuticsSteroid-induced osteoporosisGPhC CRA

A 66-year-old starts prednisolone 30 mg daily for polymyalgia rheumatica. She is expected to continue corticosteroid treatment for several months. She asks why bone protection has been mentioned. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Assessment of fracture risk and bone protection need

Long-term systemic corticosteroids increase fracture risk and may require bone protection depending on risk assessment. Calcium, vitamin D and bisphosphonate therapy may be considered according to individual risk. Theophylline and INR monitoring are not routine bone safety measures. Pregnancy testing is not relevant to this patient.

Reference: NICE CKS; BNF